Li Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Li Xiao has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Wei Huang
Department of Obstetrics and Gynecology, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, China
4 shared publications Tianji Liao
Hospital Center for Reproductive Medicine Second University
2 shared publications- Bin Luo
Division of Reproductive Medicine, West China Second University Hospital of Sichuan University, Chengdu, China
1 shared publication - Bing Peng
Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China
1 shared publication Chang Liu
Department of Obstetrics and Gynecology, Centre for Reproductive Medicine, West China Second University Hospital, Sichuan University
1 shared publicationHaibo Qu
Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education
1 shared publication
Latest Publications
- Open Access
- 6 March 2026
- Published by Taylor & Francis in Human Fertility
- Vol. 29 (1) , 2638250
Effects of E2/ERβ on follicular granulosa cells and on AMH/Smad signalling in endometriosis
Patients with endometriosis have greater risk of infertility, which is associated with compromised ovarian function. Dysfunction in follicular granulosa cells and hyperactivation of oestrogen receptor beta (ERβ) are evident in endometriosis. It is also known that anti-Müllerian hormone (AMH)/Smad signalling pathway regulates ovarian activity. In this study, we aimed to explore effects of oestradiol (E2)/ERβ on follicular granulosa cells and on AMH/Smad signalling in endometriosis. The human ovarian granulosa cells were obtained from patients with tubal factor infertility and ovarian endometriosis, respectively, who underwent IVF/ICSI-ET using GnRH antagonist protocol in our hospital. A human ovarian granulosa tumour cell line (KGN) was cultured and subject to treatments with oestradiol and/or PHTPP (a selective ERβ antagonist). Cell viability, apoptosis, migration, and invasion were assessed. The mRNA and protein expressions were also investigated. It was found that AMH/Smad signalling pathway was suppressed in human ovarian granulosa cells in patients with ovarian endometriosis. Then, in KGN cells, E2 treatment (10-10 mol/L for 72 h) did not alter cell viability or apoptosis, but E2 decreased migration and invasion via ERβ. Further, E2 inhibited AMH/Smad signalling pathway via ERβ in KGN cells. Conversely, selective inhibition of ERβ could reverse these effects. In conclusion, activation of E2/ERβ compromised the function of follicular granulosa cells in endometriosis, which may be mediated by AMH/Smad signalling pathway.
- 6 March 2026
- Published by Taylor & Francis in Human Fertility
- Vol. 29 (1) , 2638250
Open AccessEffects of E2/ERβ on follicular granulosa cells and on AMH/Smad signalling in endometriosis
Patients with endometriosis have greater risk of infertility, which is associated with compromised ovarian function. Dysfunction in follicular granulosa cells and hyperactivation of oestrogen receptor beta (ERβ) are evident in endometriosis. It is also known that anti-Müllerian hormone (AMH)/Smad signalling pathway regulates ovarian activity. In this study, we aimed to explore effects of oestradiol (E2)/ERβ on follicular granulosa cells and on AMH/Smad signalling in endometriosis. The human ovarian granulosa cells were obtained from patients with tubal factor infertility and ovarian endometriosis, respectively, who underwent IVF/ICSI-ET using GnRH antagonist protocol in our hospital. A human ovarian granulosa tumour cell line (KGN) was cultured and subject to treatments with oestradiol and/or PHTPP (a selective ERβ antagonist). Cell viability, apoptosis, migration, and invasion were assessed. The mRNA and protein expressions were also investigated. It was found that AMH/Smad signalling pathway was suppressed in human ovarian granulosa cells in patients with ovarian endometriosis. Then, in KGN cells, E2 treatment (10-10 mol/L for 72 h) did not alter cell viability or apoptosis, but E2 decreased migration and invasion via ERβ. Further, E2 inhibited AMH/Smad signalling pathway via ERβ in KGN cells. Conversely, selective inhibition of ERβ could reverse these effects. In conclusion, activation of E2/ERβ compromised the function of follicular granulosa cells in endometriosis, which may be mediated by AMH/Smad signalling pathway.
- Open Access
- 28 September 2025
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 52 (9)
The Value of Routine Hysteroscopy Before First Embryo Transfer in Infertile Women With a History of Ectopic Pregnancy: A Propensity Score-Matched Analysis
Background: Ectopic pregnancy is a major early-pregnancy cause of maternal mortality, and hysteroscopy is the gold standard for uterine cavity assessment, offering direct visualization, accurate pathology, easy biopsy, and immediate therapeutic intervention. However, no studies have evaluated whether hysteroscopy improves subsequent pregnancy outcomes in infertile women with a prior ectopic pregnancy. This study aimed to evaluate the necessity of routine office hysteroscopy prior to the first embryo transfer in infertile women with a history of ectopic pregnancy, based on the hypothesis that hysteroscopy may assist in identifying intrauterine pathologies that could impact pregnancy outcomes. Methods: We conducted a single-center retrospective cohort study including consecutive patients with a history of ectopic pregnancy at a university-affiliated hospital between January 2018 and December 2022. Patients were divided into two groups according to whether they underwent hysteroscopy prior to embryo transfer. Propensity score matching (PSM) was applied to balance baseline characteristics between the groups. Results: A total of 714 patients were included in the analysis. Following PSM, no significant differences in baseline characteristics were observed between the two groups. The clinical pregnancy rate was 58.26% in the hysteroscopy group and 53.22% in the non-hysteroscopy group (p = 0.397). Subgroup analysis revealed that patients diagnosed with and treated for chronic endometritis (CE) exhibited a higher spontaneous miscarriage rate (46.90%) and a lower live birth rate (25.00%) compared to the disease-free group (miscarriage rate 18.00%, live birth rate 45.61%), the endometrial polyps (EP) group (miscarriage rate 10.00%, live birth rate 52.31%), and CE + EP group (miscarriage rate 25.00%, live birth rate 44.26%). Conclusions: Routine hysteroscopy prior to first embryo transfer in women with a history of ectopic pregnancy did not significantly improve clinical pregnancy rates. However, hysteroscopy proved valuable in identifying intrauterine abnormalities such as CE and EP, which were associated with adverse reproductive outcomes. Further prospective studies are warranted to determine whether targeted diagnosis and management of these conditions can improve live birth rates in this population.
- 28 September 2025
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 52 (9)
Open AccessThe Value of Routine Hysteroscopy Before First Embryo Transfer in Infertile Women With a History of Ectopic Pregnancy: A Propensity Score-Matched Analysis
Background: Ectopic pregnancy is a major early-pregnancy cause of maternal mortality, and hysteroscopy is the gold standard for uterine cavity assessment, offering direct visualization, accurate pathology, easy biopsy, and immediate therapeutic intervention. However, no studies have evaluated whether hysteroscopy improves subsequent pregnancy outcomes in infertile women with a prior ectopic pregnancy. This study aimed to evaluate the necessity of routine office hysteroscopy prior to the first embryo transfer in infertile women with a history of ectopic pregnancy, based on the hypothesis that hysteroscopy may assist in identifying intrauterine pathologies that could impact pregnancy outcomes. Methods: We conducted a single-center retrospective cohort study including consecutive patients with a history of ectopic pregnancy at a university-affiliated hospital between January 2018 and December 2022. Patients were divided into two groups according to whether they underwent hysteroscopy prior to embryo transfer. Propensity score matching (PSM) was applied to balance baseline characteristics between the groups. Results: A total of 714 patients were included in the analysis. Following PSM, no significant differences in baseline characteristics were observed between the two groups. The clinical pregnancy rate was 58.26% in the hysteroscopy group and 53.22% in the non-hysteroscopy group (p = 0.397). Subgroup analysis revealed that patients diagnosed with and treated for chronic endometritis (CE) exhibited a higher spontaneous miscarriage rate (46.90%) and a lower live birth rate (25.00%) compared to the disease-free group (miscarriage rate 18.00%, live birth rate 45.61%), the endometrial polyps (EP) group (miscarriage rate 10.00%, live birth rate 52.31%), and CE + EP group (miscarriage rate 25.00%, live birth rate 44.26%). Conclusions: Routine hysteroscopy prior to first embryo transfer in women with a history of ectopic pregnancy did not significantly improve clinical pregnancy rates. However, hysteroscopy proved valuable in identifying intrauterine abnormalities such as CE and EP, which were associated with adverse reproductive outcomes. Further prospective studies are warranted to determine whether targeted diagnosis and management of these conditions can improve live birth rates in this population.
- Open Access
- 31 July 2025
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 52 (8) , 39882
Environmental Chemicals and Female Reproductive Health: Unraveling Mechanisms and Societal Impacts — A Narrative Review
Objectives: To examine the impacts of environmental chemicals on female reproductive health, identify key mechanisms of reproductive toxicity, and discuss potential strategies to mitigate these effects. Mechanism: Environmental chemicals such as per- and polyfluoroalkyl substances, heavy metals, pesticides, microplastics, quaternary ammonium compounds, and other pollutants, disrupt the hypothalamic-pituitary-gonadal axis (HPG), impair ovarian function, and contribute to reproductive dysfunction through mechanisms such as oxidative stress, hormonal disruption, and epigenetic modifications. Findings in Brief: These chemicals contribute to menstrual irregularities, infertility, and pregnancy complications. They also increase the risk of reproductive system disorders, including endometriosis, polycystic ovary syndrome (PCOS), and ovarian cancer. Additionally, transgenerational effects mediated by epigenetic modifications, germ cell damage, and placental transfer may adversely affect offspring health, increasing the risk of reproductive dysfunction, neurodevelopmental disorders, metabolic diseases, and cancer. Conclusions: Despite growing evidence, significant knowledge gaps remain in understanding the mechanisms of reproductive toxicity, identifying biomarkers for early detection, and assessing the long-term effects of low-dose, chronic exposure. Addressing these challenges requires stricter regulations, the development of safer chemical alternatives, public awareness campaigns, and continued research to safeguard reproductive health for current and future generations.
- 31 July 2025
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 52 (8) , 39882
Open AccessEnvironmental Chemicals and Female Reproductive Health: Unraveling Mechanisms and Societal Impacts — A Narrative Review
Objectives: To examine the impacts of environmental chemicals on female reproductive health, identify key mechanisms of reproductive toxicity, and discuss potential strategies to mitigate these effects. Mechanism: Environmental chemicals such as per- and polyfluoroalkyl substances, heavy metals, pesticides, microplastics, quaternary ammonium compounds, and other pollutants, disrupt the hypothalamic-pituitary-gonadal axis (HPG), impair ovarian function, and contribute to reproductive dysfunction through mechanisms such as oxidative stress, hormonal disruption, and epigenetic modifications. Findings in Brief: These chemicals contribute to menstrual irregularities, infertility, and pregnancy complications. They also increase the risk of reproductive system disorders, including endometriosis, polycystic ovary syndrome (PCOS), and ovarian cancer. Additionally, transgenerational effects mediated by epigenetic modifications, germ cell damage, and placental transfer may adversely affect offspring health, increasing the risk of reproductive dysfunction, neurodevelopmental disorders, metabolic diseases, and cancer. Conclusions: Despite growing evidence, significant knowledge gaps remain in understanding the mechanisms of reproductive toxicity, identifying biomarkers for early detection, and assessing the long-term effects of low-dose, chronic exposure. Addressing these challenges requires stricter regulations, the development of safer chemical alternatives, public awareness campaigns, and continued research to safeguard reproductive health for current and future generations.
- Open Access
- 9 August 2024
- Published by Springer Nature in Research Square
Is it necessary to perform a routine hysteroscopy before first embryo transfer in patients with previous ectopic pregnancy history: A propensity score matching analysis?
Purpose To determine whether an office hysteroscopy is required before the first embryo transfer in infertile women with previous ectopic pregnancy history. Methods Consecutive patients with previous ectopic pregnancy history were categorized into two groups based on the performance of hysteroscopy. Subgroup 1 consisted of patients whose endometrial pathology was normal, subgroup 2 who were diagnosed with endometrial polyps (EP), and subgroup 3 diagnosed with chronic endometritis (CE). Demographics, baselines of characteristics, and pregnancy outcomes after embryo transfer were compared among these groups. Results A total of 614 patients were enrolled. No differences were observed in the baseline characteristics of these groups. The clinical pregnancy rates were comparable between hysteroscopy group and non-hysteroscopy group. The spontaneous miscarriage rate was greater in the cured CE subgroup compared to the normal and EP subgroups. Consequently, the live birth rate was comparatively lower in the cured CE group than in both the control group and the EP group. Conclusions We found a high pregnancy loss rate in women with CE-confirmed immunohistochemically. While office hysteroscopy serves as a valuable diagnostic instrument, it is imperative that it be supplemented with appropriate and adequate antibiotic therapy. Further investigation is still required before it can be considered a standard infertile workup before the first embryo transfer in patients with previous ectopic pregnancy history. Trial registration N/A.
- 9 August 2024
- Published by Springer Nature in Research Square
Open AccessIs it necessary to perform a routine hysteroscopy before first embryo transfer in patients with previous ectopic pregnancy history: A propensity score matching analysis?
Purpose To determine whether an office hysteroscopy is required before the first embryo transfer in infertile women with previous ectopic pregnancy history. Methods Consecutive patients with previous ectopic pregnancy history were categorized into two groups based on the performance of hysteroscopy. Subgroup 1 consisted of patients whose endometrial pathology was normal, subgroup 2 who were diagnosed with endometrial polyps (EP), and subgroup 3 diagnosed with chronic endometritis (CE). Demographics, baselines of characteristics, and pregnancy outcomes after embryo transfer were compared among these groups. Results A total of 614 patients were enrolled. No differences were observed in the baseline characteristics of these groups. The clinical pregnancy rates were comparable between hysteroscopy group and non-hysteroscopy group. The spontaneous miscarriage rate was greater in the cured CE subgroup compared to the normal and EP subgroups. Consequently, the live birth rate was comparatively lower in the cured CE group than in both the control group and the EP group. Conclusions We found a high pregnancy loss rate in women with CE-confirmed immunohistochemically. While office hysteroscopy serves as a valuable diagnostic instrument, it is imperative that it be supplemented with appropriate and adequate antibiotic therapy. Further investigation is still required before it can be considered a standard infertile workup before the first embryo transfer in patients with previous ectopic pregnancy history. Trial registration N/A.
- Open Access
- 3 February 2022
- Published by Springer Nature in Reproductive Sciences
- Vol. 29 (12) , 3532
Correction to: Comparative Proteomic Analysis Reveals Metformin Improves the Expression of Biomarkers of Endometrial Receptivity in Infertile Women with Minimal/Mild Endometriosis
- 3 February 2022
- Published by Springer Nature in Reproductive Sciences
- Vol. 29 (12) , 3532
Open AccessCorrection to: Comparative Proteomic Analysis Reveals Metformin Improves the Expression of Biomarkers of Endometrial Receptivity in Infertile Women with Minimal/Mild Endometriosis
- Open Access
- 13 July 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (7) , e0234086
MicroRNA22-5p targets ten-eleven translocation and regulates estrogen receptor 2 expression in infertile women with minimal/mild endometriosis during implantation window
Based on microRNA (miR) microarray analysis, we previously found that miR22-5p expression is decreased in the mid-luteal endometrium of women with minimal/mild endometriosis. Bioinformatics analysis predicted that miR22-5p targets ten-eleven translocation (TET2) 3′-untranslated region. This study aimed to determine the regulation and roles of miR22-5p in the pathogenesis of minimal/mild endometriosis-associated infertility. MiR22-5p and TET2 expression in the mid-luteal endometrium from women with or without minimal/mild endometriosis was analyzed. After transfection with miR22-5p mimics or inhibitor, TET2 expression was analyzed by quantitative reverse transcription (RT-q) PCR, western blotting and immunohistochemistry. 5-Hydroxymethylcytosine was determined by immunofluorescence and dot blotting. Expression and promoter methylation of estrogen receptor 2 (ESR2) was measured by RT-qPCR and western blotting, and by bisulfite sequencing, respectively. We first established that miR22-5p expression decreased and TET2 expression increased in minimal/mild endometriosis during implantation window. TET2 was found to be a direct target of miR22-5p. MiR22-5p regulated the expression of ESR2, but did not directly affect methylation of its promoter region (–197/+359). Our results suggest that an imbalance in miR22-5p expression in the mid-luteal endometrium may be involved in minimal/mild endometriosis-associated infertility.
- 13 July 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (7) , e0234086
Open AccessMicroRNA22-5p targets ten-eleven translocation and regulates estrogen receptor 2 expression in infertile women with minimal/mild endometriosis during implantation window
Based on microRNA (miR) microarray analysis, we previously found that miR22-5p expression is decreased in the mid-luteal endometrium of women with minimal/mild endometriosis. Bioinformatics analysis predicted that miR22-5p targets ten-eleven translocation (TET2) 3′-untranslated region. This study aimed to determine the regulation and roles of miR22-5p in the pathogenesis of minimal/mild endometriosis-associated infertility. MiR22-5p and TET2 expression in the mid-luteal endometrium from women with or without minimal/mild endometriosis was analyzed. After transfection with miR22-5p mimics or inhibitor, TET2 expression was analyzed by quantitative reverse transcription (RT-q) PCR, western blotting and immunohistochemistry. 5-Hydroxymethylcytosine was determined by immunofluorescence and dot blotting. Expression and promoter methylation of estrogen receptor 2 (ESR2) was measured by RT-qPCR and western blotting, and by bisulfite sequencing, respectively. We first established that miR22-5p expression decreased and TET2 expression increased in minimal/mild endometriosis during implantation window. TET2 was found to be a direct target of miR22-5p. MiR22-5p regulated the expression of ESR2, but did not directly affect methylation of its promoter region (–197/+359). Our results suggest that an imbalance in miR22-5p expression in the mid-luteal endometrium may be involved in minimal/mild endometriosis-associated infertility.
- Open Access
- 1 May 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (19) , e19932
Successful management of Klippel–Trenaunay syndrome in a pregnant Asian woman
Rationale: Klippel–Trenaunay Syndrome (KTS) is a congenital vascular disease characterized by cutaneous hemangiomas, venous varicosities, and limb hypertrophy. Although extremely rare in pregnant women, the present vascular alterations may be aggravated, consequent to postural and hormonal changes inherent to the pregnancy. Pregnancy is not advised in KTS women due to increased obstetrical risk. Patient concerns: A 31-year-old pregnancy woman presented with prominent vascularity in pelvis, right lower limb, spleen, and liver at 28 weeks of gestation. We started administration of anticoagulant therapy and obstetrics management. Diagnosis: MRI and ultrasound revealed that multiple varicosities in her pelvis, right lower limb, spleen, and liver. She was diagnosed with KTS. Interventions: At her first visit at 28 weeks of gestation, multidisciplinary evaluation had been done. Blood transfusion and iron supplement had been given for anemia correction. Anticoagulant therapy was performed to prevent potential thrombus risk. She had a vaginal delivery with a healthy newborn in her second visit without any complications at the gestation of 36+6 weeks due to rupture of preterm membranes. Outcomes: After successful management, the patient was discharged without any complications 2 days after vaginal delivery. No symptoms of hemorrhage or thrombus were observed. At 6 months follow-up, her right lower toes enlarged obviously, MRI revealed that no obvious changes of hemangiomas was found compared to those during the pregnancy and ultrasound revealed that there was no thrombus in her right lower limb. Lessons: Patients with KTS can be pregnant and have healthy babies safely with regularly monitor and reasonable treatment during pregnancy. A careful follow-up and guidance are necessary.
- 1 May 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (19) , e19932
Open AccessSuccessful management of Klippel–Trenaunay syndrome in a pregnant Asian woman
Rationale: Klippel–Trenaunay Syndrome (KTS) is a congenital vascular disease characterized by cutaneous hemangiomas, venous varicosities, and limb hypertrophy. Although extremely rare in pregnant women, the present vascular alterations may be aggravated, consequent to postural and hormonal changes inherent to the pregnancy. Pregnancy is not advised in KTS women due to increased obstetrical risk. Patient concerns: A 31-year-old pregnancy woman presented with prominent vascularity in pelvis, right lower limb, spleen, and liver at 28 weeks of gestation. We started administration of anticoagulant therapy and obstetrics management. Diagnosis: MRI and ultrasound revealed that multiple varicosities in her pelvis, right lower limb, spleen, and liver. She was diagnosed with KTS. Interventions: At her first visit at 28 weeks of gestation, multidisciplinary evaluation had been done. Blood transfusion and iron supplement had been given for anemia correction. Anticoagulant therapy was performed to prevent potential thrombus risk. She had a vaginal delivery with a healthy newborn in her second visit without any complications at the gestation of 36+6 weeks due to rupture of preterm membranes. Outcomes: After successful management, the patient was discharged without any complications 2 days after vaginal delivery. No symptoms of hemorrhage or thrombus were observed. At 6 months follow-up, her right lower toes enlarged obviously, MRI revealed that no obvious changes of hemangiomas was found compared to those during the pregnancy and ultrasound revealed that there was no thrombus in her right lower limb. Lessons: Patients with KTS can be pregnant and have healthy babies safely with regularly monitor and reasonable treatment during pregnancy. A careful follow-up and guidance are necessary.